⌘K

Login Start Free

Home/Filings/4/0001209191-18-000968

4//SEC Filing

Graney Thomas 4

Accession 0001209191-18-000968

CIK 0000875320other

View on SEC.gov Company Profile

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 4:49 PM ET

Size

4.7 KB

Accession

0001209191-18-000968

Insider Transaction Report

Form 4

Period: 2018-01-02

VERTEX PHARMACEUTICALS INC / MAVRTX

Chief Financial Officer

Transactions

Sale
Common Stock
2018-01-02$149.95/sh−777$116,511→ 8,789 total

Footnotes (1)

[F1]Transaction made pursuant to Mr. Graney's company-approved trading plan under Rule 10b5-1.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

VERTEX PHARMACEUTICALS INC / MA

CIK 0000875320

Entity typeother

Related Parties

1

filerCIK 0001618275

Filing Metadata

Form type: 4
Filed: Jan 2, 7:00 PM ET
Accepted: Jan 3, 4:49 PM ET
Size: 4.7 KB

View on SEC.gov